Palermo G D, Colombero L T, Schattman G L, Davis O K, Rosenwaks Z
Center for Reproductive Medicine and Infertility, Department of Obstetrics and Gynecology, The New York Hospital-Cornell Medical Center, New York, NY 10021-4872, USA.
JAMA. 1996 Dec 18;276(23):1893-7.
To analyze the in vivo development of embryos conceived after intracytoplasmic sperm injection (ICSI), as well as obstetric outcome, occurrence of chromosomal abnormalities, and rate of congenital malformations in neonates born as a result of this treatment.
Retrospective study.
University-based in vitro fertilization (IVF) clinic.
A total of 751 couples in whom the male partners were presumed to be the cause of repeated failed IVF attempts or whose semen parameters were unacceptable for conventional IVF treatment.
Analysis of pregnancies resulting from 987 ICSI cycles; pregnancy outcome data were obtained from the records of obstetrician-gynecologists and/or pediatricians.
Pregnancy rates, obstetric outcome, and frequency of chromosomal abnormalities and congenital malformations.
The overall clinical pregnancy (fetal heartbeat) rate was 44.3%, with a resultant delivery rate per ICSI cycle of 38.7% (n=382). In 8 of 11 miscarriages for which cytogenetic data were available, an autosomal trisomy was found, and 7 additional pregnancies were terminated because of a chromosomal abnormality after prenatal diagnosis. There was an equal distribution of vaginal vs cesarean deliveries (n=192 and n=190, respectively). Of the 578 neonates resulting from treatment by ICSI, 15 (2.6%) presented with congenital abnormalities (9 major and 6 minor abnormalities). However, this frequency of malformations is lower than that observed in offspring born after standard IVF at our institution. Furthermore, when pregnancy outcome of ICSI vs IVF was analyzed in terms of semen origin, no differences were found in the frequency of miscarriages or in the rate of congenital malformations.
The evolution of pregnancies and occurrence of congenital malformations following treatment by ICSI were within the range observed with standard in vitro fertilization.
分析卵胞浆内单精子注射(ICSI)后受孕胚胎的体内发育情况,以及该治疗所产新生儿的产科结局、染色体异常发生率和先天性畸形率。
回顾性研究。
大学附属体外受精(IVF)诊所。
共751对夫妇,其男性伴侣被认为是IVF反复失败的原因,或其精液参数不符合常规IVF治疗要求。
分析987个ICSI周期后的妊娠情况;妊娠结局数据从妇产科医生和/或儿科医生的记录中获取。
妊娠率、产科结局以及染色体异常和先天性畸形的发生率。
总体临床妊娠(有胎心)率为44.3%,每个ICSI周期的分娩率为38.7%(n = 382)。在可获得细胞遗传学数据的11例流产中,有8例发现常染色体三体,另外7例在产前诊断出染色体异常后终止妊娠。阴道分娩和剖宫产的分布相同(分别为n = 192和n = 190)。在578例ICSI治疗出生的新生儿中,15例(2.6%)出现先天性异常(9例主要异常和6例次要异常)。然而,这种畸形发生率低于我们机构标准IVF后出生的后代。此外,根据精液来源分析ICSI与IVF的妊娠结局时,流产频率或先天性畸形率没有差异。
ICSI治疗后妊娠的进展和先天性畸形的发生在标准体外受精观察到的范围内。